21 CFR 10.110
§ 10.110 Settlement proposals.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 10.110, § 10.110 Settlement proposals, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/83071
- Permanent ID
ys:prov:83071@1- SHA-256
963f6d252a708b885eb2807cc869ed78b5217345c75b1050cdfae7b95e2eea2c
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
At any time in the course of a proceeding subject to this part, a person may propose settlement of the issues involved. A participant in a proceeding will have an opportunity to consider a proposed settlement. Unaccepted proposals of settlement and related matters, e.g., proposed stipulations not agreed to, will not be admissible in evidence in an FDA administrative proceeding. FDA will oppose the admission in evidence of settlement information in a court proceeding or in another administrative proceeding.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.